in past times few years, the united kingdom has witnessed a revolution in clinical body weight‑loss treatment plans — through the introduction of semaglutide (Wegovy®) to the expanding reputation of tirzepatide (Mounjaro®). Now, One more identify is drawing interest in both equally scientific and